Steven J. Hamerslag, a director at CorVel Corporation, has reported the sale of 11,000 shares of the company’s common stock. This transaction, valued at approximately $920,040, is significant as it highlights ongoing activities within the insurance agents and brokers sector.

The sale was executed on November 11, 2026, and reported on November 12, 2026, due to the EDGAR system's unavailability on the federal holiday. The transaction was facilitated by J.P. Morgan Securities LLC, which served as the broker.

Background

CorVel Corporation, identified by the Central Index Key (CIK) 0000874866, operates in the insurance agents, brokers, and services industry (SIC 6411). The company is incorporated in Delaware and has its fiscal year ending on March 31. Recent filings show consistent activity from Hamerslag, including a Form 4 filing just a day after this transaction.

What the Filing Says

The shares filed today were sold on 11/11/26 by the Steven J. Hamerslag and Jean Wells Hamerslag Trust Dtd 12/09/88, Steven J. Hamerslag as Trustee and is being reported on this Form 144 filed on 11/12/26 given the EDGAR system was not accepting filings on 11/11/26 in observance of the federal holiday.

Impact

This sale may impact stakeholders, including investors and analysts monitoring CorVel Corporation's stock performance. As a director, Hamerslag's actions could influence market perceptions and the company's governance dynamics.

What's Next

The filing does not say what happens next.